Ann Morgan


Ann is the Head of the Molecular and Personalised Medicine Group within the Leeds Institute of Cardiovascular and Metabolic Medicine. Ann graduated from the University of Leeds with first class honours in Pathology and a Bachelor of Medicine and Surgery with Honours, having achieved distinctions in Biochemistry and Surgery, and Prizes in Medicine and Surgery. She chose a clinical career in rheumatology and subsequently undertook a PhD studying Fcg Receptor genetics in rheumatoid arthritis, supported by an MRC Clinical Training Fellowship. She continued my research in Fcg Receptor biology during an Arthritis Research UK/Academy of Medical Sciences Clinician Scientist Fellowship. The award of HEFCE Clinical Senior Lectureship allowed her to continue her work on the FcgRs, whilst developing new academic interests in genetic and soluble biomarkers and disease outcomes.

Her main clinical interests are vasculitis and rare autoimmune diseases, and she lead the regional Behçets syndrome and large vessel vasculitis services.

Ann’s active research projects range from laboratory studies to large data analysis and she also undertakes patient-focused research. Ann Chairs both the UK GCA Consortium and the MRC TARGET Partnership and is establishing an expanding research programme in vascular biology.